Member Info for RCMPMounties

Https://otce.finra.org/otce/dailyList

Perhaps from looking at this

SANTIAGO666

"When did you buy back in lol? Doh!!"

He didn't, just making it up as he goes along as usual haha

Someone bought in here today at 2.3p and are already 30% down 🙄

Another tick up - 1.25 / 1.30 now :))

After decades of having a presence out in Bolivia with all the cordial relations and discussions and noise made about the Lithium and the best they can come up with is that they are hoping for an MOU? Maybe they are better off just giving up as it looks as though nothing is ever going to materialise. Investors would have got a better return putting money into a savings account than parking here for eternity!

"Taking money out of this and putting it in Bloe would be financial suicide."

Yep couldn't agree more :)

Decent buys coming in - should tick up soon

Creeping up again :))

Next leg up coming - not much left below 3p

I notice the donkey they call goingtomoonufo has been quiet lately - probably having an allergic reaction to the start of the huge re-rate :))

"GENinCode’s US commercialisation strategy includes a targeted engagement plan focused on the top 250 US physicians in lipidology and preventive cardiology. The Company is also building partnerships with key opinion leaders (KOLs) and major institutions, supported by education programmes and the SITAB portal.

Service-based testing is expanding across institutions, community clinics, and executive health settings. In addition, commercial payer discussions are progressing, focusing on benefits investigation and securing out-of-network coverage.

The Company has now successfully onboarded over 48 top-tier institutional sites (up from 20 in 2024), mainly for the use of LIPID inCode with adoption expected to grow further following CARDIO inCode-Score FDA approval and insurance coverage. The Total Addressable Market (TAM) for CiC-Score is estimated at $10.5 billion, with a Serviceable Available Market (SAM) of $4.5 billion. Initial market scoping indicates an addressable patient pool of 21 million, with 8.5 million likely to be prescribed CiC-Score if covered by insurance.

In December, the Company announced a commercial agreement with Sohin Genetics in Mexico to distribute its CARDIO inCode-Score® Polygenic Risk Score test. Sohin Genetics will promote and market the test across its network of hospitals and clinics, leveraging GENinCode’s SITAB international reporting system."

"The updated 2026 ACC/AHA Dyslipidemia Guidelines were published on Friday representing the most significant update to U.S. cardiovascular risk assessment and lipid management over the past decade. Alongside the inclusion of the new PREVENT clinical risk equation and greater emphasis on treatment goals, from a genetic perspective we are delighted to see the new guidelines recognise an individual’s Coronary Artery Disease Polygenic Risk Score (‘CAD PRS’) as a new ‘risk enhancing factor’. CAD PRS helps identify individuals in the population at higher risk to refine cardiovascular risk assessment. The adoption of genetics to enable ‘earlier in life’ cardiovascular risk assessment is compelling, particularly in younger adults or those with borderline/intermediate clinical risk and as an aid to decision-making for earlier treatment e.g. statin initiation and/or to intensify lifestyle change and improved patient education to prevent CAD. "

"GENinCode and our partners have developed CARDIO inCode-Score (CAD PRS) and LIPID inCode tests over the past 15 years and have amassed a significant body of clinical evidence to support the utility of CAD PRS. "

Seems to have levelled off, hopefully next update will send this to the moon!

Last thing we need here today or tomorrow are more TR1s with holders offloading :(

Next leg up - 2.50p on the ask now

Just topped up @ 1.15 thanks Douglas 😊

Jumped to 1.30 bid and 1.35 ask

Buys landing every minute 🤔

In last 20mins 🤔 @1.279 and 1.29

Bid creeping back up 👀

Don't be fooled by the drop - the upside is huge here!